Agnis Combi 50 mg/1000 mg filmsko obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

agnis combi 50 mg/1000 mg filmsko obložene tablete

metformin; vildagliptin - filmsko obložena tableta - metformin 780 mg / 1 tableta  vildagliptin50 mg / 1 tableta; vildagliptin 50 mg / 1 tableta - metformin in vildagliptin

Agnis Combi 50 mg/1000 mg filmsko obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

agnis combi 50 mg/1000 mg filmsko obložene tablete

metformin; vildagliptin - filmsko obložena tableta - metformin 780 mg / 1 tableta  vildagliptin50 mg / 1 tableta; vildagliptin 50 mg / 1 tableta - metformin in vildagliptin

Lekoptin 240 mg tablete s podaljšanim sproščanjem Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lekoptin 240 mg tablete s podaljšanim sproščanjem

lek d.d. - verapamil - tableta s podaljšanim sproščanjem - verapamil 223,1 mg / 1 tableta - verapamil

Lekoptin 40 mg obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lekoptin 40 mg obložene tablete

lek d.d. - verapamil - obložena tableta - verapamil 37,2 mg / 1 tableta verapamilijev klorid - verapamil

Vildagliptin / Metformin hydrochloride Accord Evropska unija - slovenščina - EMA (European Medicines Agency)

vildagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 in 5. 1 za razpoložljive podatke o različnih kombinacijah).